Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda

Irene Andia, Angela Kaida, Marissa Maier, David Guzman, Nneka Emenyonu, Larry Pepper, David Bangsberg, Robert S. Hogg

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objectives. We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. Methods. We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. Results. Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95% confidence interval [CI]=1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR=3.62; 95% CI=1.54, 8.55) than were women not receiving HAART. Conclusions. Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.

Original languageEnglish (US)
Pages (from-to)340-347
Number of pages8
JournalAmerican Journal of Public Health
Volume99
Issue number2
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Fingerprint

Uganda
Highly Active Antiretroviral Therapy
Contraceptive Agents
HIV
Barrier Contraception
Contraception
Therapeutics
Odds Ratio
Confidence Intervals
Reproductive Health
Acquired Immunodeficiency Syndrome
Cross-Sectional Studies
Logistic Models

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. / Andia, Irene; Kaida, Angela; Maier, Marissa; Guzman, David; Emenyonu, Nneka; Pepper, Larry; Bangsberg, David; Hogg, Robert S.

In: American Journal of Public Health, Vol. 99, No. 2, 01.02.2009, p. 340-347.

Research output: Contribution to journalArticle

Andia, Irene ; Kaida, Angela ; Maier, Marissa ; Guzman, David ; Emenyonu, Nneka ; Pepper, Larry ; Bangsberg, David ; Hogg, Robert S. / Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. In: American Journal of Public Health. 2009 ; Vol. 99, No. 2. pp. 340-347.
@article{1dbc4b6e1d0045deb56e033e0e0d65b3,
title = "Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda",
abstract = "Objectives. We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. Methods. We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45{\%} of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. Results. Overall, 45{\%} of the women were sexually active in the previous 3 months. Of these, 85{\%} reported using contraceptive methods, with 84{\%} reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95{\%} confidence interval [CI]=1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR=3.62; 95{\%} CI=1.54, 8.55) than were women not receiving HAART. Conclusions. Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.",
author = "Irene Andia and Angela Kaida and Marissa Maier and David Guzman and Nneka Emenyonu and Larry Pepper and David Bangsberg and Hogg, {Robert S.}",
year = "2009",
month = "2",
day = "1",
doi = "10.2105/AJPH.2007.129528",
language = "English (US)",
volume = "99",
pages = "340--347",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "2",

}

TY - JOUR

T1 - Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda

AU - Andia, Irene

AU - Kaida, Angela

AU - Maier, Marissa

AU - Guzman, David

AU - Emenyonu, Nneka

AU - Pepper, Larry

AU - Bangsberg, David

AU - Hogg, Robert S.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Objectives. We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. Methods. We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. Results. Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95% confidence interval [CI]=1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR=3.62; 95% CI=1.54, 8.55) than were women not receiving HAART. Conclusions. Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.

AB - Objectives. We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. Methods. We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. Results. Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR]=2.64; 95% confidence interval [CI]=1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR=3.62; 95% CI=1.54, 8.55) than were women not receiving HAART. Conclusions. Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.

UR - http://www.scopus.com/inward/record.url?scp=59049095372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59049095372&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2007.129528

DO - 10.2105/AJPH.2007.129528

M3 - Article

C2 - 19059862

AN - SCOPUS:59049095372

VL - 99

SP - 340

EP - 347

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 2

ER -